Explore 3 Stock Ideas & Industry Insights Download Free Report

Premium

Can CME Group (NASDAQ: CME) Maintain Its Winning Streak in Q4FY23? Key Metrics to Watch

CME Group Inc. (NASDAQ: CME)offers products across diverse asset classes, by trading futures, options, cash and over the counter (OTC) products. CME provides interest rates, equity indexes, foreign exchange (FX), agricultural commodities, energy, and metals.

Team Kalkine | 01 February 2024

BofA initiates coverage on Weatherford International with a Buy rating; stock jumps 2.5%

Shares ofWeatherford International (NASDAQ: WFRD)rose by 2.5% to reach US$97.09 following Bank of America Global Research's initiation of coverage on the company. The broker gave Weatherford a 'buy' rating and a price target, which is ~26% higher than Friday’s closing price.

Akanksha Vashisht | 13 November 2023

D.A. Davidson upgrade drives Booking Holdings’ share price 5% higher

Booking Holdings Inc.’s shares reached US$3,002.38 following an upgrade from 'neutral' to 'buy' by D.A. Davidson analysts. The stock price rose by 5% on November 6, 2023, marking the most significant price increase since early August this year.

Team Kalkine | 07 November 2023

KeyBanc’s rating upgrade pushes UBER stock price 1.1% higher

Ride-hailing and delivery companyUber Technologies Inc. (NYSE: UBER)saw its share prices rising by 1.1% after receiving a rating upgrade from broker KeyBanc. KeyBanc Capital Markets upgraded UBER to an ‘overweight’ rating from its previous ‘sector weight’.

Akanksha Vashisht | 06 November 2023

Barclays upgrades rating on these automobile stocks

Broker Barclays upgraded automakersFord (NYSE: F)andGeneral Motors (NYSE: GM)to ‘overweight’ from its previous ‘equal-weight’ rating. Shares of both the companies rose by over 1% premarket, after the rating upgrade from the broker.

Akanksha Vashisht | 05 November 2023

William Blair initiates coverage on Eyenovia with an Outperform rating

DrugmakerEyenovia Inc. (NASDAQ: EYEN)received an ‘outperform’ rating from William Blair. The broker anticipates improved delivery of ophthalmic therapies.

Akanksha Vashisht | 02 November 2023

Wells Fargo sees 22% upside potential in Gap, upgrades to Overweight

RetailerGap Inc. (NYSE: GPS)received a rating and price target upgrade from broker Wells Fargo. Praising clothing retailer Gap’s turnaround story, Wells Fargo raised its rating on the stock from ‘equal weight’ to ‘overweight’.

Akanksha Vashisht | 26 October 2023

Gene editing firm Editas obtains rating upgrade from Citi

Brokerage house Citi has increased its rating on gene editing companyEditas Medicine (NASDAQ: EDIT)from 'neutral' to 'buy'. The broker believes that there exists the potential for a positive short-term stock price rise on two key catalysts through the end of the year.

Akanksha Vashisht | 25 October 2023

Brokers upgrade Dycom to Strong Buy on favorable fiber upgrade prospects

Construction firmDycom Industries Inc. (NYSE: DY)received a rating upgrade from broker Raymond James, causing the stock price to rise by around 2% to US$83.78 on Friday. The rating upgrade came based on the forecast rise of AT&T, a key client of Dycom’s.

Akanksha Vashisht | 23 October 2023

Morgan Stanley says selloff in the clean tech industry overdone; upgrades ratings

Broker Morgan Stanley upgraded its view on the clean tech industry, stating the stock selloff caused by concerns of higher interest rate as the main reason to do so. The broker upgraded some of the stocks in the industry, centered around this positive outlook.

Akanksha Vashisht | 19 October 2023